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Extensive literature supports the correlation between surgical volume and improved clinical
outcome in the management of various cancers. It is this evidence that has catalysed the
creation of centres of excellence. However, on closer inspection, many of these studies are poor
quality, low weight and use vastly heterogenous end points in assessment of both volume and
outcome. We critically appraise the English language literature published over the last ten
years pertaining to the volume outcome relationship in the context of cancer care. Future
balanced unbiased studies may enable equipoise in planning international cancer management
strategies.
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No longer is there room for eminence-based com-
placency or misguided arrogance in healthcare
delivery. The day of the autonomous clinician is gone
with a vogue towards standardised, evidence-based
clinical excellence. Cynics would erroneously attri-
bute this to a parallel increase in litigation but
increasing patient knowledge and expectations with a
move toward subspecialisation are the main catalysts
driving change. When oﬀered operative intervention,
the question frequently asked by the patient is ‘‘How
many of these have you done before?’’ This article
aims to critically analyse recent literature and explore
the correlation between volume and clinical outcome
in the context of cancer care.
BACKGROUND
Mortality rates are reported to be inﬂuenced by the
number of particular operations performed in a given
hospital or by a speciﬁc surgeon (i.e. outcomes are
better in high-volume centres). In 1999, the US Na-
tional Cancer Policy Board recommended that pa-
tients requiring complex procedures be transferred
from low- to high-volume hospitals in its report
entitled ‘‘Ensuring Quality Cancer Care’’.1 The fol-
lowing year, the Institute of Medicine held a work-
shop to discuss cancer care, publishing a document
(‘‘Interpreting the Volume-Outcome Relationship in
the Context of Cancer Care’’2) which concluded that
existing evidence was strong enough to recommend
the regionalisation of high-risk operations. Hence,
the impact of volume on outcome has been assessed
in several tumour types but the majority of data re-
lates to gastrointestinal, hepatobiliary, urological,
and breast cancers.
THE LITERATURE
Patients undergoing pancreatic and oesophageal
procedures have lower operative mortality and
shorter hospital stay in the hands of experienced
surgeons in high-volume units.3 With regard to gas-
tric cancer, the ﬁndings are less consistent. Some
suggest that high-volume centres have lower in-house
mortality4 but no change in long-term survival.5
Various end points have been examined in colorectal
cancer (Table 1). Schrang and Billingsley both
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showed that it was surgeon-speciﬁc experience com-
bined with multidisciplinary support rather than
centre experience that afforded signiﬁcant survival
advantage.6,7
Comprehensive albeit retrospective studies
unequivocally state that patients who undergo radical
prostatectomy at lower-volume institutions are at sig-
niﬁcant risk of requiring adjuvant therapy due to ad-
verse surgical factors, prolonged hospital admission,
increased hospital charges and postoperative compli-
cations.8 The hospital structure of high-volume units,
including easy availability of consultative, diagnostic
and ancillary services, were cited as likely contributors
to the association between procedure volume and
short-term cystectomy outcomes.9 A minimum case
load of only 11 radical cystectomies per year was cited
to be associated with the lowest mortality rate.10
Less certainty exists in relation to breast cancer but
a variety of end points have been examined, including
number of visits required to obtain a nonoperative
diagnosis, mastectomy rates for <15 mm tumours
and rate of referral for adjuvant radiotherapy.11
Skinner et al. were adamant that volume alone could
not be used as a surrogate for expertise but, like most
studies, conceded that patients with breast cancer
operated on in high-volume units compared to very
low-volume units had better survival. However there
is ambiguity surrounding the exact causal relation-
ship: volume effect alone versus surgical skill versus
appropriate use of adjuvant therapy.12
THE FLAWS
The majority of studies are poor quality, heterog-
enous and potentially ﬂawed. Even the best literature
stems from retrospective review of large databases
which are up to 40% inaccurate13 and pertain to se-
lected patient groups. Most papers are published
from a few very high-volume US centres, thus
introducing immediate potential for bias. No consis-
tent end point is used and, incredibly, few studies
explore cancer-speciﬁc outcomes. Mortality rates,
when not corrected for comorbidities or stage at
diagnosis, are poor surrogates for more robust com-
parators of volume–outcome analysis such as cancer-
specific survival, patient satisfaction and quality of
life.
American data cannot be used as a basis for the
formation of European cancer strategies because so
many inherent diﬀerences exist. These include earlier
disease stage at time of operation (a function of
screening),14 wide variance in population15 and
socioeconomic status16 as well as insured versus
noninsured outcomes.17 Comparison of very high-
volume centres and very low-volume centres is as
redundant as measuring revenue from a supermarket
versus a corner store. Is it not intuitive that analysis
of such extremes will yield vastly different results?
Looking at the structure–process–outcome model,
structure is relatively fixed (health service, institution)
but process is entirely variable and volume is but one
component of it. Therefore, in the absence of multi-
variable data, subgroup analysis is entirely inappro-
priate, rendering the aforementioned studies at best
biased, at worst invalid.
The Surgeon
To identify procedure volume in a single institution
is easy but not so for quantifying speciﬁc operations
done by a single surgeon, many of whom practise in
several centres. Without asking individuals to record
caseload prospectively, obtaining accurate ﬁgures
may be very diﬃcult. Surely signiﬁcant bias could
occur in that those willing to share details of opera-
tions may be conﬁdent of their own justiﬁcation in
performing such procedures. Furthermore, who
counts as more experienced: a mature surgeon who
has performed two colonic resections a week for
20 years but now does only two a month or a
younger, specialist trained surgeon who performs
TABLE 1. Colorectal cancer outcome: high- and low-volume units
High volume Low volume Ref.
APR versus LAR ﬂ APR › APR Meyerhardt et al. 19
› LAR ﬂ LAR
Sphincter preservation › › ﬂ Purves et al.20
30-day postoperative mortality M M Schrag et al.21
Survival (overall and cancer speciﬁc) › ﬂ Schrag et al.21
Permanent stoma formation ﬂ › McGrath et al.22
Colonic pouch formation › ﬂ McGrath et al.22
APR, abdominoperineal resection; LAR, low anterior resection.
› increased, ﬂ decreased, M no variation.
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three a week? How do you weight lifetime experience
against current volume? Should a centralised data-
base of surgeons logbooks exist, and should per-
mission to operate be granted or denied based on
this? What governing body should be aﬀorded such a
task? Should operating surgeons be ranked in their
ability or would this border on defamation for the
less fortunate ones? Regarding referral pattern, does
volume attract quantity or do excellent clinicians at-
tract patients? Many studies have compared the sig-
niﬁcance of surgeon experience to unit volume with
varied conclusions as to which has more impact. Do
excellent surgeons naturally aggregate in excellent
high-volume units, thus giving a self-propagating
explanation for improved outcome?
The Institution
Many papers allude to the importance of the
multidisciplinary approach in cancer care. Higher-
volume units are far more likely to have subspecia-
lised radiologists, radiation and medical oncologists,
high dependency and intensive care units, cancer
specialist nurses, dedicated psychologists and pallia-
tive care support. Anecdotally, the involvement of
such services translates into better patient outcome
regardless of unit volume, thus confounding results.
The resounding evidence in favour of the volume–
outcome relationship pertains to those cancers
requiring adjuvant therapy: oesophagus, pancreas
and advanced colorectal. It seems, therefore, that
good surgical technique or individual surgeon expe-
rience do not exclusively guarantee positive outcomes
and that much depends on availability of radiation
and medical oncology.
More often than not, within a short period of the
introduction of a new service, its resources are satu-
rated. At what point does a dedicated unit declare
that available services can no longer provide for pa-
tient throughput? The worry is that potential exists
for patients to receive suboptimal care just before this
saturation point is reached (Fig. 1). Surely stretched
resources in a high-volume centre are just as dan-
gerous as absence of resources in smaller institution.
A study on the difference in time lapse between
diagnosis and intervention between institutions with
different volumes would be welcome. Would prog-
nosis be improved if a patient with aggressive disease
underwent early intervention at a lower-volume cen-
tre rather than late intervention at a higher-volume
centre? As cancer management is a dynamic process,
the question of safety in transferring postoperative
follow-up of a patient operated on in a high-volume
unit to a less experienced lower-volume local centre is
a pertinent one. On the other hand, should surgery be
performed in low-volume units and adjuvant thera-
pies in specialist centres? Without a doubt, the idea of
hospital units functioning as a syncitium rather than
single buildings must be engendered and skill-
appropriate tasks assigned to each component, as
recommended in breast cancer management by the
Clinical Oncology Information Network (COIN)
group.18
The Patient
Quality of life and patient satisfaction, apart from
in colorectal and prostate cancers, are largely ignored
when assessing impact of volume on clinical outcome.
Is it preferential for elderly patients to travel long
distances for management of a low-grade tumour or
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FIG. 1. Volume–outcome relation-
ship.
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would they be better served by treatment in a lower-
volume local centre where follow-up will be on their
doorstep? Decisions like this are made on a daily
basis in the context of primary care and so this begs
the question of higher-volume specialist centres
receiving selected patient cohorts, thus falsely
improving outcome. This is conﬁrmed by Morris et
al. who showed that patients treated in the Australian
private sector were likely to be younger, male and to
have an earlier disease stage.17
THE FUTURE
The literature supports a correlation between sur-
gical volume and improved clinical outcome in cancer
care. However, a rather simplistic approach is evident
in many studies and much potential remains for
unbiased, prospective, statistically sound investiga-
tions with the aim of numerically stratifying appro-
priate volume and its impact on disease speciﬁc
cancer outcomes.
While traditionally graph 1 inFig. 1 has beenused to
represent the volume–outcome relationship, it seems
probable that it is more accurately represented by
graph 2 in Fig. 1, and can be interpreted as an area
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